HOME >> BIOLOGY >> NEWS
Sequence matters when using novel agent

TORONTO - An experimental agent that targets a cancer cell's protein shredding machinery (the proteasome) should be given either before or with taxane-based chemotherapy drugs, but not after, say researchers at The University of Texas M. D. Anderson Cancer Center who conducted laboratory tests using prostate cancer cells.

The finding is important because the new therapy, known as PS-341 (Velcade), will likely be tried as new treatment for a number of cancers due to its effectiveness in multiple myeloma, says Christos Papandreou, M.D., Ph.D., assistant professor in the department of Genitourinary Medical Oncology.

"It appears PS-341 could become quite a hit as a novel proteasome inhibitor, a drug that increases the effectiveness of chemotherapy agents," Papandreou says. "We know that while the sequence it is used in doesn't matter with certain classes of chemotherapy drugs, it does with others. Hopefully, future clinical trials will reflect this new understanding."

The findings were published in the Proceedings for the 2003 Annual Meeting of the American Association for Cancer Research.

Last summer, the agent demonstrated a dramatic success when used to treat patients with multiple myeloma. Researchers at Dana-Farber Cancer Institute, where it was tested, said 70 percent of 78 patients with advanced multiple myeloma improved - an unheard of benefit in that disease. The agent is now being used in a Phase II clinical trial in advanced prostate cancer, and several Phase I clinical trials are underway, or have been completed, testing PS-341 in pancreatic, lung and colorectal cancers.

The drug is designed to specifically inhibit proteasomes, the cell's enzymatic protein-shredding machinery, responsible for breaking down a variety of proteins, including many that regulate cell division.

M. D. Anderson researchers designed experiments in which they treated prostate cancer cells with PS-341 alone or in combination with
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
9-Apr-2003


Page: 1 2

Related biology news :

1. Sequence of human chromosome 7 is fine-tuned and finished
2. Sequenced malaria genome exposes novel drug targets
3. Sequence provides insights into a pathogens virulence mechanism allowing for vaccine development
4. New Science Press launches Proteins: From Sequence to Structure
5. Sequencers take a bird in hand
6. Genetic Stowaways May Contribute To Evolutionary Change: Adjacent Sequences Tag Along With Mobile DNA Elements, Study Shows
7. Scientists Sequence Chlamydia Trachomatis Genome
8. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
9. Syphilis Genome Sequence Offers Clues To Better Diagnosis, Prevention And Treatment
10. Why some animals have smaller eyes: Lifestyle matters
11. Why genetic diversity matters

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable energy ... operations in the fight against the COVID-19 pandemic in Zambia. , One of ...
(Date:6/23/2020)... Texas (PRWEB) , ... June 23, 2020 , ... ... analytical instrumentation, is pleased to announce the next event in a series of ... scattering. , The TOPIQ series of webinars was developed in response to social ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem ... that if the stem cell medicine and pharmaceutical industries have easier access to stem ... So, starting July 5 of this year, Independence Day weekend in the U.S., Asymmetrex ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... LEXINGTON, Ky. (PRWEB) , ... August 03, 2020 , ... ... innovative products for transformative growth, , Known as MediVet Biologics ... Health brand. , The new Ardent Animal Health will build on its ...
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified Technologies, ... that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. , ... or two switches in a push-pull configuration; yielding fast fall time for a ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
Breaking Biology Technology:
Cached News: